Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 247,033 | 119,294 | 204,221 | 253,946 | 286,679 |
| Receivables | 888,288 | 896,535 | 888,253 | 832,873 | 888,115 |
| Inventories | 80,857 | 79,715 | 86,501 | 102,125 | 98,818 |
| Income taxes - deferred | 154,983 | 154,017 | 206,980 | 218,419 | 182,056 |
| TOTAL | $1,470,682 | $1,339,098 | $1,484,557 | $1,496,819 | $1,551,567 |
| Non-Current Assets | |||||
| PPE Net | 831,946 | 843,757 | 861,898 | 879,687 | 873,434 |
| Intangibles | 5,920,429 | 5,886,587 | 5,856,486 | 5,882,329 | 5,979,760 |
| Other Non-Current Assets | 142,667 | 141,993 | 143,692 | 144,995 | 163,995 |
| TOTAL | $6,895,042 | $6,872,337 | $6,862,076 | $6,907,011 | $7,017,189 |
| Total Assets | $8,365,725 | $8,211,435 | $8,346,633 | $8,403,830 | $8,568,756 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 103,872 | 204,969 | 5,014 | 5,142 | 49,919 |
| Accounts payable and accrued liabilities | 886,973 | 818,907 | 1,261,336 | 1,219,619 | 1,190,914 |
| TOTAL | $990,845 | $1,023,876 | $1,266,350 | $1,224,761 | $1,240,833 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,877,734 | 2,877,767 | 3,077,171 | 3,078,089 | 3,078,421 |
| aiOther Non-Current Liabilities | 549,623 | 533,981 | 462,227 | 467,625 | 508,914 |
| TOTAL | $3,436,773 | $3,421,917 | $3,547,952 | $3,553,935 | $3,595,939 |
| Total Liabilities | $4,427,618 | $4,445,793 | $4,814,302 | $4,778,696 | $4,836,772 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 184,901 | 185,747 | 185,373 | 190,575 | 195,608 |
| Common Shares | 2,141 | 2,141 | 2,141 | 2,141 | 2,141 |
| Retained earnings | 3,053,421 | 2,879,722 | 2,710,170 | 2,561,679 | 2,410,907 |
| Other shareholders' equity | 11,161 | -31,391 | -64,041 | -47,751 | -14,162 |
| TOTAL | $3,938,107 | $3,765,642 | $3,532,331 | $3,625,134 | $3,731,984 |
| Total Liabilities And Equity | $8,365,725 | $8,211,435 | $8,346,633 | $8,403,830 | $8,568,756 |